NEWS

bacterias-intestinales-370x247
Stellate Therapeutics Strengthens Senior Management Team

Press Release

David Immke joins as Chief Scientific Officer and Jonathan Weiss as Director of Business Development
Read more
Image1
Stellate Therapeutics Appoints Sophie Durand as Chief Executive Officer and Announces Capital Raise

Press Release

- Sophie Durand appointed Chief Executive Officer to guide Stellate Therapeutics towards clinical trials
- Investment from eureKARE to bring long-term expertise, financial and operational support
Read more